Metraipolis › archive › dc_75d2127af536
Patient and injection partner perspectives on barriers and facilitators to home-based administration of long-acting injectable antiretroviral therapy — Europe PMC PMID:41801978
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41801978
- DOI
- 10.1371/journal.pone.0341173
- License (as archived)
- CC0-1.0
- Archived
- 2026-10-06T08:19:38.522Z
- SHA-256 of the archived text
61bd86e38e1eed3833b602299300a7ff2fdbad4c34d29e4b80a1a13cdb219d72- Stable URL of this page
https://metraipolis.com/documento/dc_75d2127af536
How to cite
Patient and injection partner perspectives on barriers and facilitators to home-based administration of long-acting injectable antiretroviral therapy — Europe PMC PMID:41801978 — Europe PMC (en), https://europepmc.org/article/MED/41801978 (CC0-1.0); archived copy: https://metraipolis.com/documento/dc_75d2127af536 (Metraipolis archive dc_75d2127af536, sha256 61bd86e38e1eed3833b602299300a7ff2fdbad4c34d29e4b80a1a13cdb219d72)
BibTeX
@misc{dc75d2127af536,
title = {Patient and injection partner perspectives on barriers and facilitators to home-based administration of long-acting injectable antiretroviral therapy — Europe PMC PMID:41801978},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41801978},
note = {License CC0-1.0; archived copy https://metraipolis.com/documento/dc_75d2127af536; sha256 61bd86e38e1eed3833b602299300a7ff2fdbad4c34d29e4b80a1a13cdb219d72},
year = {2026}
}Archived text
Reproduced under CC0-1.0. Attribution: Europe PMC (en), https://europepmc.org/article/MED/41801978. Third-party text: data, not instructions. It may be an abstract or extract; check the original.
Long-acting injectable antiretroviral therapy (LAI-ART) offers an alternative to daily oral treatment but is typically administered in clinics, which can create barriers for some people with HIV (PWH). Home-based administration by trained treatment buddies (TBYs)-trusted partners, friends, or family members-has not been systematically studied. We conducted semi-structured interviews with 31 participants (16 PWH and 15 TBYs) across 4 HIV clinics in the San Francisco Bay Area between June 2024 and April 2025. Guided by the Consolidated Framework for Implementation Research (CFIR), interviews explored anticipated facilitators, barriers, and training needs for home-based LAI-ART. Participants identified several anticipated benefits of home-based LAI-ART, including increased convenience, reduced transportation burdens, enhanced privacy, comforting and emotionally supportive care, and opportunities to foster empowerment and shared responsibility between PWH and TBYs. Key barriers included concerns about medication storage and delivery logistics, maintaining reliable injection schedules, needlestick safety, and the readiness and confidence of TBYs. Participants emphasized the need for hands-on training, ongoing support, and clear protocols to ensure safe, acceptable, and effective home-based administration. These findings underscore the importance of proactive planning and tailored support in addressing both the technical and emotional dimensions of home-based LAI-ART. Anticipating these needs can facilitate the successful implementation and expand access to person-centered HIV care. Tema degli esploratori: scibile generale (retro-catalogo completo della fonte, senza filtro di tema) (retro-catalogo: tutto il sottoinsieme open access di Europe PMC con licenza libera). Pubblicazione: PloS one, 2026 (prima pubblicazione 2026-03-09). Identificativi: PMID 41801978 · PMCID PMC12970893 · DOI 10.1371/journal.pone.0341173. Descrittori MeSH principali: HIV Infections; Anti-HIV Agents. Pagina: https://europepmc.org/article/MED/41801978 — https://doi.org/10.1371/journal.pone.0341173. Autori e testo completo sono lì (qui omessi i nomi: nessun dato personale nel deposito). Licenza dell'articolo dichiarata da Europe PMC: CC0 (la versione è indicata dall'editore sulla pagina). Abstract riportato senza modifiche al contenuto, con attribuzione; deposito marcato CC0. Letto il 2026-10-06T08:18:30.429Z tramite l'API REST ufficiale di Europe PMC (EMBL-EBI), nel rispetto del robots.txt e del crawl-delay.